The DOI matches its Crossref record; 99 of the 104 references it cites were found in a registry or an index.
Epigenetic gene silencing in cancer: the DNA hypermethylome
Open accessAbstract
Epigenetic gene inactivation in transformed cells involves many 'belts of silencing'. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the epigenetic landscape of human malignancies exhibits massive reprogramming in their DNA methylation patterns.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Cited by
Items 301–400 of 725
Gan, J., Zhang, D. X., He, D. L., Zhang, X. Q., Chen, Z. Y., & Luo, Q. B. (2013) · Genetics and Molecular Research · doi:10.4238/2013.march.15.1 · Cited by 26
Peng, D., Guo, Y. P., Chen, H., Zhao, S., Washington, K. M., Hu, T., Shyr, Y., & El-Rifai, W. M. (2017) · Scientific Reports · doi:10.1038/srep40729 · Cited by 26
Regulation of Human RNA Polymerase III Transcription by DNMT1 and DNMT3a DNA Methyltransferases
Selvakumar, T., Gjidoda, A., Hovde, S., & Henry, R. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285601 · Cited by 25
Heery, R., & Schaefer, M. H. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1167 · Cited by 27
Wang, X., Chen, M., Liang, X., Bai, Y., Zeng, J., Xu, X., Li, H., Wang, J., Fan, K., & Zhao, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.752511 · Cited by 25
Lee, J.-Y., Jeong, W., Lim, W., Lim, C.-H., Bae, S.-M., Kim, J. Y., Bazer, F. W., & Song, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061658 · Cited by 26
“These results support the idea that epigenetic silencing of tumor suppressor genes by promoter CpG island hypermethylation is one of the most important regulatory mechanisms leading to the generation and proliferation of carcinomas [25].”
ResultEpigenetic therapy in myeloproliferative neoplasms: evidence and perspectives
Vannucchi, A. M., Guglielmelli, P., Rambaldi, A., Bogani, C., & Barbui, T. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00827.x · Cited by 25
“Hypermethylation at specific gene loci, particularly of tumour-suppressor genes, and global hypomethylation of genomic DNA, as well as inactivation of microRNA genes by DNA methylation [69, 70], are all common findings in human cancer cells [69–71].”
BackgroundSilencing of the UCHL1 gene in giant cell tumors of bone
Fellenberg, J., Lehner, B., & Witte, D. (2010) · International Journal of Cancer · doi:10.1002/ijc.25205 · Cited by 25
“Growing evidence exists that promoter CpG hypermethylation plays a fundamental role in this context causing dysregulation and inactivation of gene expression especially in the earliest steps of tumor initiation.(13,14) In particular, epigenetic silencing of tumor suppressor genes is thought to be a common feature of h…”
BackgroundDNA methylation analysis in constitutional disorders: Clinical implications of the epigenome
Schenkel, L. C., Rodenhiser, D. I., Ainsworth, P., Paré, G., & Sadiković, B. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1113496 · Cited by 27
Hsieh, T., Liu, Y., Chang, T.-Y., Liang, M., Chen, H., Wang, H., Yen, Y., & Wong, T. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox186 · Cited by 26
White-opaque switching in Candida albicans : cell biology, regulation, and function
Soll, D. R. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00043-22 · Cited by 32
Oyinlade, O., Wei, S., Kammers, K., Liu, S., Wang, S., Ma, D., Huang, Z., Qian, J. X., Zhu, H., Wan, J., et al. (2018) · Epigenetics · doi:10.1080/15592294.2018.1504592 · Cited by 26
The Role of Epigenetics in Arterial Calcification
Wu, S., Lin, X., Yuan, L., & Liao, E.-Y. (2015) · BioMed Research International · doi:10.1155/2015/320849 · Cited by 28
“Themechanism of silencing can bemainly through (1) the promotion of methylated DNA in the recruitment of methyl-CpG-binding domain (MBD) proteins which, in turn, recruit histone-modifying and chromatin-remodelling complexes to methylated sites [65, 66] or (2) a preclusion in the recruitment of DNA binding proteins fro…”
BackgroundDNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence
Benard, A., Zeestraten, E. C. M., Goossens-Beumer, I. J., Putter, H., van de Velde, C. J. �., Hoon, D. S. �., & Kuppen, P. J. K. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1022-z · Cited by 26
Jinsong, J., Pękowska, A., Jaeger, S., Benoukraf, T., Ferrier, P., & Spicuglia, S. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-240 · Cited by 24
“On the other hand, cancer cells undergo dramatic changes in the level and distribution of DNA methylation [2].”
BackgroundEpigenetics in BIOLOGY and MEDICINE
(2008) · CRC Press eBooks · doi:10.1201/9781420007077 · Cited by 27
Using epigenomic studies in monozygotic twins to improve our understanding of cancer
Roos, L., Spector, T. D., & Bell, C. G. (2014) · Epigenomics · doi:10.2217/epi.14.13 · Cited by 23
Tseng, R., Chang, J.-W., Mao, J.-S., Tsai, C.-D., Wu, P.-C., Lin, C.-J., Lu, Y.-L., Liao, S., Cheng, H.-C., Hsu, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6229 · Cited by 23
“Given that promoter hypermethylation is able to produce transcriptional silencing of a target gene [23], we further examined the promoter methylation of the GAS7C gene in lung cancer patients.”
BackgroundDNA Methylation of Tumor-Suppressor miRNA Genes in Chronic Lymphocytic Leukemia
Wang, L. Q., & Chim, C. S. (2015) · Epigenomics · doi:10.2217/epi.15.6 · Cited by 22
Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer
Knight (1992) · International Journal of Oncology · doi:10.3892/ijo_00000171 · Cited by 28
Immunological Effects of Epigenetic Modifiers
Bezu, L., Chuang, A. W., Liu, P., Kroemer, G., & Kepp, O. (2019) · Cancers · doi:10.3390/cancers11121911 · Cited by 25
“Nevertheless, this complex network includes some regulatory checkpoints that can be detected, such as the hypermethylation of certain promoters, and can be directly or indirectly targeted by therapeutic agents, such as the DNMT inhibitor 5-aza-2’-deoxycytidine (decitabine) that is used for the treatment of myelodyspla…”
BackgroundMethylation of tumor suppressor genes is related with copy number aberrations in breast cancer.
Murria, R., Palanca, S., de Juan, I., Egoavil, C. M., Alenda, C., García‐Casado, Z., Juan, M. J., Sánchez, A. B., Santaballa, A., Chirivella, I., et al. (2015) · Europe PMC (PubMed Central) · Cited by 22
Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice
Ward, A., Morettin, A., Shum, D., & Hudson, J. W. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-71 · Cited by 22
“Recently it has become evident that the hypermethylation of CpG islands of tumour-suppressor genes, histone modification and chromatin remodelling are common events in cancers (for review see [10]).”
BackgroundPromoter hypermethylation of DNA damage response genes in hepatocellular carcinoma
Li, Z., Zhang, H., Yang, J., Tielai, H., & Li, S. (2011) · Cell Biology International · doi:10.1042/cbi20100851 · Cited by 22
“These genes have been implicated by demonstrating a significant correlation between CpG island methylation and loss of mRNA or protein expression (Esteller, 2007).”
BackgroundDNMT3B7 Expression Promotes Tumor Progression to a More Aggressive Phenotype in Breast Cancer Cells
Brambert, P. R., Kelpsch, D. J., Hameed, R., Desai, C. V., Calafiore, G., Godley, L. A., & Raimondi, S. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117310 · Cited by 22
“Cancer cells are characterized by abnormal DNA methylation patterns compared to normal cells[2,3].”
BackgroundCiapa, B., & Arnoult, C. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103122bc · Cited by 25
Gordián, E. R., Ramachandran, K. J., & Singal, R. (2009) · PubMed · Cited by 22
Nutrition, Epigenetic Mechanisms, and Human Disease
Maulik, N., & Maulik, G. (2010) · CRC Press eBooks · doi:10.1201/b10449 · Cited by 83
Zhang, C., Peng, Y., Yang, F., Qin, R., Liu, W., & Zhang, C. (2016) · Journal of Cancer · doi:10.7150/jca.13065 · Cited by 22
“ation of TSGs is one of the hallmarks in cancer initiation and progression [4-6], some of the tumor-specific methylated TSGs detected in early or late stage of cancer could function as diagnostic or prognostic biomarkers [7-9].”
BackgroundGuo, W., Dong, Z., Shi, Y., Liu, S., Liang, J., Guo, Y., Guo, X., Shen, S., & Shan, B. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.05.010 · Cited by 23
Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance
Naghizadeh, S., Mansoori, B., Mohammadi, A., Sakhinia, E., & Baradaran, B. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180403141554 · Cited by 22
Wu, Y., Li, J., Sun, C., Zhou, Y., Zhao, Y., & ZHANG, S. J. (2012) · Neoplasma · doi:10.4149/neo_2012_042 · Cited by 22
“Clinically, the identification of genes with abnormal methylation and consequently become silenced is of critical importance since this provides us a source of new valuable cancer markers and potential therapeutic targets [24].”
BackgroundChiang, Y., Chang, M.-C., Chen, P., Wu, M., Hsieh, C., Cheng, W., & Chen, C. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0117 · Cited by 22
“Aberrant DNA methylation is a common phenomenon in malignancy and methylation profiles are different in various tumors which might be associated with clinical outcomes (Esteller 2007).”
BackgroundLeón‐González, A. J., Jara-Palacios, M. J., Abbas, M., Heredia, F. J., & Schini‐Kerth, V. B. (2017) · Food & Function · doi:10.1039/c7fo00263g · Cited by 21
DNA methylation, bacteria and airway inflammation
Perez-Novo, C. A., & Bachert, C. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000130 · Cited by 22
“DNMT3A and DNMT3B are classified as de-novo DNMTs, which are responsible for establishing the pattern of methylation during embryonic development [7,8].”
BackgroundSmolková, B., Kataki, A., Earl, J., Ruz‐Caracuel, I., Cihova, M., Urbanova, M., Buociková, V., Tamargo, S., Rovīte, V., Niedra, H., et al. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103865 · Cited by 21
Epigenetic therapy in allogeneic hematopoietic stem cell transplantation
Bashir, Q., William, B. M., Garcia‐Manero, G., & de Lima, M. (2013) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20130034 · Cited by 20
“CpG island promoter methylation may affect multiple pathways involved in apoptosis, cell cycle and DNA repair, for example(3).”
BackgroundWang, F., Hu, Y., Feng, Y., Guo, Y., Liu, Y., Mao, Q., & Xue, W. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25448 · Cited by 20
“DNA methylation is a common and important mechanism in the regulation of eukaryotic gene expression, and changes in the normal methylation patterns of the genome are closely tied to tumor occurrence and development.(26) Hypermethylation can inhibit transcription of promoter regions in tumor suppressor genes, by which…”
BackgroundWang, S.-C., Liao, L., Ansar, M., Lin, S.-Y., Hsu, W., Su, C.-M., Chung, Y.-M., Liu, C.-C., Hung, C., & Lin, R.-K. (2021) · Cancers · doi:10.3390/cancers13061375 · Cited by 21
“Promoter hypermethylation of certain genes appears to be an early event in breast cancer carcinogenesis, and this process is mediated through the silencing of tumor suppressor genes involved in cell cycle regulation, DNA repair, transformation, signal transduction, adhesion and metastasis [84].”
BackgroundEpigenetic Drugs and Their Immune Modulating Potential in Cancers
Liang, Y., & Turcan, Ş. (2022) · Biomedicines · doi:10.3390/biomedicines10020211 · Cited by 21
“Sporadic DNA hypomethylation can be located in the gene body regions of oncogenes [21,22].”
BackgroundTargeting Twist expression with small molecules
Pei, H., Li, Y., Liu, M., & Chen, Y. (2016) · MedChemComm · doi:10.1039/c6md00561f · Cited by 19
MBD2 Ablation Impairs Lymphopoiesis and Impedes Progression and Maintenance of T-ALL
Zhou, M., Zhou, K., Cheng, L., Chen, X., Wang, J., Wang, X., Zhang, Y., Yu, Q., Zhang, S., Wang, D., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1434 · Cited by 20
“Aberrant DNA methylation patterns in tumor cells represent attractive and novel therapeutic targets(5-7).”
BackgroundTian, X., Yu, H. T., Li, D., Jin, G., Dai, S., Gong, P., Kong, C., & Wang, X. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.022 · Cited by 19
“Snail transcriptional activity correlates positively with cancer progression, which is mainly induced by metastasis, and poor prognosis in various tumors.16,17 Snail represses a wide range of EMT-related genes, such as CDH1, VIM, CLDN1, CLDN3, and VDR, via epigenetic regulation.18,19 Gene silencing in mammalian cells…”
BackgroundSamuelsson, J. K., Alonso, S., Yamamoto, F., & Perucho, M. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.08.010 · Cited by 21
“Since that seminal discovery, numerous genes have been found to undergo promoter hypermethylation in a large variety of cancers [23].”
BackgroundLin, L., Chamberlain, L., Pak, M. L., Nagarajan, A. G., Gupta, R., Zhu, L. J., Wright, C. M., Fong, K. M., Wajapeyee, N., & Green, M. R. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0747 · Cited by 19
Jiang, Y., Huang, Y., Cheng, C., Lu, W., Zhang, Y., Liu, X., Zou, L., Ben, Q., & Shen, A. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.09.007 · Cited by 21
The Expression of microRNA-223 and FAM5C in Cerebral Infarction Patients with Diabetes Mellitus
Long, Y., Zhan, Q., Yuan, M., Duan, X., Zhou, J., Lü, J., Li, Z., Yu, F., Zhou, X., Yang, Q., et al. (2015) · Cardiovascular Toxicology · doi:10.1007/s12012-015-9354-7 · Cited by 20
Establishing a Biological Profile for Interval Colorectal Cancers
Cisyk, A. L., Singh, H., & McManus, K. J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3210-7 · Cited by 19
Deactylase inhibition in myeloproliferative neoplasms
Mithraprabhu, S., Grigoriadis, G., Khong, T. T., & Spencer, A. G. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9590-4 · Cited by 19
“Collectively, these post-translational modifications of histones and DNA methylation result in transcriptional silencing of tumour suppressor and cell differentiation genes, thus promoting cell survival by blocking apoptosis and senescence.”
BackgroundInfluentialGhosh, D., Chakravarti, R., Lenka, S. K., Gautam, A., Singh, R., Ravichandiran, V., & Roy, S. (2022) · Current Drug Targets · doi:10.2174/1389450123666220117105531 · Cited by 18
Epigenetic Role of miRNAs in Normal and Leukemic Hematopoiesis
Pagano, F., Marinis, E. D., Grignani, F., & Nervi, C. (2013) · Epigenomics · doi:10.2217/epi.13.55 · Cited by 19
Poplineau, M., Schnekenburger, M., Dufer, J., Kosciarz, A., Brassart‐Pasco, S., Antonicelli, F. D., Diederich, M. F., & Trussardi‐Régnier, A. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22071 · Cited by 18
“DNAmethylation is usually associated with gene silencing [14] either by interfering with the transcriptional machinery [15] or by recruiting chromatin repressors such as methyl-binding proteins (MBD1-4, MeCP2 or Kaiso proteins), histone deacetylases (HDACs) or histone methyltransferases (HMTs) [16].”
BackgroundExcavating relics of DNA methylation changes during the development of neoplasia
Hsiao, S., Huang, T. H. ‐., & Leu, Y. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.02.015 · Cited by 19
Gündüz, E., Gündüz, M., BEDER, L. B., Nagatsuka, H., Fukushima, K., Sütçü, R., Delibaş, N., Yamanaka, N., Shimizu, K., & Nagai, N. (2009) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archoto.2008.560 · Cited by 18
“These hemizygous TSGs showed a tumor-prone phenotype when challenged with carcinogens.21,22 Moreover, promoter methylation has also been attributed to the inactivation mechanism of TSG.23 Whether haploinsufficiency or pro- moter methylation occurs, the result is a decrease in mRNA expression and then possibly a decrea…”
BackgroundGuo, X. B., Guo, L., Zhi, Q. M., Ji, J. F., Jiang, J. L., Zhang, R. J., Zhang, J. N., Zhang, J., Chen, X. H., Cai, Q., et al. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06808.x · Cited by 17
Intronic CpG content and alternative splicing in human genes containing a single cassette exon
Malousi, A., Maglaveras, N., & Kouidou, S. (2008) · Epigenetics · doi:10.4161/epi.3.2.6066 · Cited by 21
“(3) Only internal exons either constitutive or cassette were considered.”
BackgroundPulverer, W., Wielscher, M., Panzer‐Grümayer, R., Plessl, T., Kriegner, A., Vierlinger, K., & Weinhäusel, A. (2012) · Biochimie · doi:10.1016/j.biochi.2012.06.023 · Cited by 17
DNA methylation pattern of apoptosis‐related genes in ameloblastoma
Costa, S., Nb, P., Pereira, K. M. A., Campos, K., Castro, W., Diniz, M., Gomes, C. C., & Gomez, R. S. (2017) · Oral Diseases · doi:10.1111/odi.12661 · Cited by 17
“Studies indicate that aberrant DNA methylation of the promoter region of specific genes, such as tumour suppressor genes, is related to tumourigenesis in different types of the neoplastic diseases, including head and neck cancer (Esteller, 2007; Demokan and Dalay, 2011).”
BackgroundChronic Toxoplasma gondii Infection Exacerbates Secondary Polymicrobial Sepsis
de Souza, M. C. N., da Fonseca, D. M., Kanashiro, A., Benevides, L., Medina, T. D. S., Dias, M. S., Andrade, W. A., Bonfá, G., Silva, M. A. B., Gozzi, A., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00116 · Cited by 19
“For the methylation analysis, CD4+ T cells were separated from spleen cells by negative selection for DNA extraction.”
BackgroundInfluentialInterplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Yadav, P., Bandyopadhayaya, S., Ford, B. M., & Mandal, C. C. (2021) · Current Drug Targets · doi:10.2174/1389450122666210120141546 · Cited by 17
CRISPR/Cas9 in epigenetics studies of health and disease
Sar, P., & Dalai, S. K. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.022 · Cited by 21
Chick Embryo Extract Demethylates Tumor Suppressor Genes in Osteosarcoma Cells
Mu, X., Sultankulov, B., Agarwal, R., Mahjoub, A., Schott, T., Greco, N., Huard, J., & Weiss, K. R. (2013) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-013-3104-6 · Cited by 17
“For tumor cells, the epigenetic silencing of tumor suppressor genes is associated with tumor formation and progression [2, 9, 14].”
BackgroundYu, Y., Su, K., Hsieh, M., Wang, S.-S., Wang, P.-H., Weng, W., & Yang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093635 · Cited by 17
“Epigenetic changes by DNA methylation at CG dinucleotide sites (CpGs) are frequent events in tumor development [6,7].”
BackgroundLi, Q., O’Malley, M. E., Bartlett, D. L., & Guo, S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-63 · Cited by 19
Foekens, J. A., Wang, Y., Martens, J. W. M., Berns, E. M. J. J., & Klijn, J. G. M. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.003 · Cited by 17
Johansson, I., Lauss, M., Holm, K., Staaf, J., Nilsson, C., Fjällskog, M.-L., Ringnér, M., & Hedenfalk, I. A. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.013 · Cited by 17
“Epigenetic changes are stable and heritable during cell division (Jovanovic et al., 2010), and cytosine methylation is one of the most commonly studied epigenetic changes in cancer (Esteller, 2007).”
Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer
Kirk, N. A., Kim, K., & Park, K.-S. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00905-x · Cited by 17
Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells
Ciaco, S., Mazzoleni, V., Javed, A., Eiler, S., Ruff, M., Mousli, M., Mori, M., & Mély, Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106616 · Cited by 16
Yang, Y., Mei, H., Han, X., Zhang, X., Cheng, J., Zhang, Z., Wang, H., & Xu, H. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00508-y · Cited by 17
“This situation is common with tumor-specific promoters, which are often epigenetically silenced in normal cells [20].”
BackgroundSimultaneous Methylation Profiling of Tumor Suppressor Genes in Head and Neck Cancer
Yalniz, Z., Demokan, S., Süoğlu, Y., Ulusan, M., & Dalay, N. (2010) · DNA and Cell Biology · doi:10.1089/dna.2010.1090 · Cited by 16
“This results in transcriptional silencing of the genes analogous to the effect of certain mutations (Esteller, 2007; Jones and Baylin, 2002) and has been shown to affect the prognosis, recurrence, and even induction of secondary tumors in different types of cancer ( Jones and Baylin, 2002; Brock et al.”
InfluentialProlonged Treatment with DNMT Inhibitors Induces Distinct Effects in Promoters and Gene-Bodies
Wong, Y. F., Jakt, L. M., & Nishikawa, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071099 · Cited by 19
“The hypermethylation of CGIs located in promoter regions of tumour suppressor genes is now recognized as an important mechanism for gene inactivation [5].”
BackgroundDatta, J., Ghoshal, K., Motiwala, T., & Jacob, S. T. (2012) · Genes & Cancer · doi:10.1177/1947601912452665 · Cited by 16
“DNA hypermethylation specific to the promoter regions is usually accompanied by recruitment of methyl-C binding proteins (MBDs), co-repressors such as histone deacetylases (HDACs), and histone methyltransferases (HMTs), resulting in silencing of the methylated genes.(4,5) A hallmark of almost all types of cancer is gl…”
BackgroundBunch, B. L., Krishnan, N., Greenspan, R. D., Ramakrishnan, S., Attwood, K. M., Yan, L., Qi, Q., Wang, D., Morrison, C., Omilian, A. R., et al. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1638693 · Cited by 16
“Epigenetic changes, such as DNA methylation and histone modifications, contribute to tumorigenesis [27].”
BackgroundKarlow, J. A., Miao, B., Xing, X., Wang, T., & Zhang, B. (2021) · Communications Biology · doi:10.1038/s42003-021-02094-1 · Cited by 17
DNA N6-Adenine methylation in HBV-related hepatocellular carcinoma
Cui, H., Rong, W., Ma, J., Zhu, Q. C., Jiang, B., Zhang, L., Li, C., Zhuo, Z., & Chen, M. (2022) · Gene · doi:10.1016/j.gene.2022.146353 · Cited by 15
A role for the Werner syndrome protein in epigenetic inactivation of the pluripotency factor Oct4
Smith, J. A., Ndoye, A., Geary, K. R., Lisanti, M. P., Igoucheva, O., & Daniel, R. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00585.x · Cited by 17
“Finally, the role of WRNp in Oct4 inactivation may suggest a new link between tumor formation and WRNp. WRN is a tumor suppressor gene, and its mutations or epigenetic inactivation has been associated with tumorigenesis (Hickson, 2003; Esteller, 2007; Bohr, 2008).”
Martínez, R. (2012) · Journal of Signal Transduction · doi:10.1155/2012/519807 · Cited by 21
“Nevertheless, the whole scenario including global DNA hypomethylation, aberrant promoter hypermethylation, histone modification, chromatin states, and the role of noncoding RNAs in gliomas has only been partially revealed.”
Aberrant DNMT3B7 expression correlates to tissue type, stage, and survival across cancers
Siddiqui, S., White, M., Schroeder, A. M., DeLuca, N. V., Leszczynski, A. L., & Raimondi, S. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201522 · Cited by 17
Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects
Zhang, H., Felthaus, O., Eigenberger, A., Klein, S., & Prantl, L. (2024) · Cells · doi:10.3390/cells13181526 · Cited by 20
Role of epigenetics in corneal health and disease
Sood, S., Tiwari, A., Sangwan, J., Vohra, M., Sinha, N. R., Tripathi, R., Sangwan, V., & Mohan, R. R. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101318 · Cited by 15
Contribution of DNA methylation and EZH2 in SRBC down-regulation in gastric cancer
Rezaei, S., Feizi, M. A. H., Moaddab, S. Y., & Safaralizadeh, R. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05619-9 · Cited by 16
Notomi, R., Sasaki, S., & Taniguchi, Y. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1110 · Cited by 15
Progressing from Gene Mutations to Cancer
Fearon, E. R., & Bommer, G. T. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50017-8 · Cited by 15
Bazhin, A. V., Smet, C. D., Golovastova, M. O., Schmidt, J., & Philippov, P. P. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01126.x · Cited by 15
Fraczek, J., Vinken, M., Tourwé, D. A., Vanhaecke, T., & Rogiers, V. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9659-8 · Cited by 15
“The transcriptional consequence of a gene promoter methylation event is an inactivation of the corresponding gene [2, 3]. It has been well documented that, both regional hyper- and global hypomethylation anomalies, as well as deregulation of DNMT activity are cornerstones and ultimately hallmarks of carcinogenic lesio…”
BackgroundAnti‐metastatic Action of Non‐steroidal Anti‐inflammatory Drugs
Hung, W. (2008) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(08)70162-1 · Cited by 15
“Epigenetic silencing by DNA methylation of tumor suppressor genes (like SPARC and TSPs) is a general event found in cancer cells [65].”
BackgroundYang, X., Shao, X., Gao, L., & Zhang, S. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw013 · Cited by 16
Impact of TET2 deficiency on iron metabolism in erythroblasts
Inokura, K., Fujiwara, T., Saito, K., Iino, T., Hatta, S., Okitsu, Y., Fukuhara, N., Onishi, Y., Ishizawa, K., Shimoda, K., et al. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.01.002 · Cited by 16
Fu, J., Zhang, J., Jin, F., Patchefsky, J., Braunewell, K., & Klein–Szanto, A. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049361 · Cited by 15
Le double jeu de l’épigénétique
Laget, S., & Defossez, P. (2008) · médecine/sciences · doi:10.1051/medsci/20082489725 · Cited by 15
Can long-read sequencing tackle the barriers, which the next-generation could not? A review
Szakállas, N., Barták, B. K., Valcz, G., Nagy, Z. B., Takács, I., & Molnar, B. A. (2024) · Pathology & Oncology Research · doi:10.3389/pore.2024.1611676 · Cited by 27
“The methylation-associated transcriptional inactivation of genes involved in cell cycle control and damage repair suggest that aberrant nucleotide methylations are hallmarks of carcinogenesis [120, 121].”
BackgroundWang, S., Zheng, Q.-Y., Hong, W.-F., Tang, B., Hsu, S.-J., Zhang, Y., Zheng, X., Zeng, Z.-C., Gao, C., Ke, A., et al. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110424 · Cited by 17
Yalcin, A., Kreutz, C., Pfeifer, D., Abdelkarim, M., Klaus, G., Timmer, J., Lübbert, M., & Hackanson, B. W. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.09.014 · Cited by 14
“…i n f o rticle history: eceived 28 July 2012 eceived in revised form 0 September 2012 ccepted 16 September 2012 vailable online 11 October 2012 a b s t r a c t Hypermethylation of CpGs in promoter regions and subsequent changes in gene expression are common features in acute myeloid leukemia (AML).”
BackgroundThe Complex Role of the ZNF224 Transcription Factor in Cancer
Cesaro, E., Sodaro, G., Montano, G., Grosso, M., Lupo, A., & Costanzo, P. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.11.003 · Cited by 15
Ben‐Dayan, M., Ow, T. J., Belbin, T. J., Wetzler, J. A., Smith, R. V., Childs, G. J., Diergaarde, B. B., Hayes, D. N., Grandis, J. R., Prystowsky, M. B., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.961 · Cited by 14
“Unlike promoter methylation, which is associated with transcriptional silencing of genes [27], CpG island hypermethylation in nonpromoter regions has been associated with transcriptional activation [28].”
BackgroundSánchez-Vega, F., Gotea, V., Chen, Y.-C., & Elnitski, L. L. (2017) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v9.i3.105 · Cited by 16
Yu, D., Zhuang, Z., Ren, J., Hu, X., Wang, Z., Zhang, J., Luo, Y., Wang, K., He, R., & Wang, Y. (2019) · Regenerative Biomaterials · doi:10.1093/rb/rbz016 · Cited by 15
“Although epigenetic alterations have been implicated in the development of many diseases [36], the role of epigenetic change, such as DNA methylation, remains relatively unclear in joint contracture.”
BackgroundHypermethylated promoters of tumor suppressor genes were identified in Crohn’s disease patients
Kim, T. O., Han, Y. K., & Yi, J. M. (2020) · Intestinal Research · doi:10.5217/ir.2019.00105 · Cited by 14
“All the genes we tested had previously been shown to be hypermethylated in a cancer-specific manner but are not methylated in normal colon tissues.(7) The location and extent of the methylated promoter regions used for bisulfite sequencing, relative to the transcription start sites of exon 1, are as follows: sFRP1: up…”
BackgroundInfluentialMolecular genetic and epigenetic analysis ofNCX2/SLC8A2at 19q13.3 in human gliomas
Qu, M., Jiao, H., Zhao, J., Ren, Z.-P., Smits, A., Kere, J., & Nistér, M. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01070.x · Cited by 14
Quinoline-based compounds can inhibit diverse enzymes that act on DNA
Zhou, J., Chen, Q., Ren, R., Yang, J., Liu, B., Horton, J. R., Chang, C., Li, C., Maksoud, L., Yang, Y., et al. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.09.007 · Cited by 13
“It has become particularly clear that promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of human cancers (Esteller, 2007; Schuebel et al., 2007; Wang et al., 2018).”
Background
Metadata
- Authors
- Esteller, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Esteller, Manel
- ORCID
- Esteller, Manel
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 16
- Issue
- R1
- Pages
- R50-R59
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2158207797
- Cited by
- 725
- References
- 104
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 34 · 2022: 35 · 2021: 29 · 2020: 17 · 2019: 35 · 2018: 38 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 36 · 2013: 56 · 2012: 62
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- epigenetic silencing, DNA hypermethylation, methylome, tumor suppressor, DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylase, histone methyltransferase, histone demethylase, Polycomb group proteins, DNA repair genes, microRNA, tumor markers, chemotherapy response prediction, epigenetic drugs, hematologic malignancies
- MeSH terms
- Werner Syndrome Helicase, Aging, Exodeoxyribonucleases, Humans, Neoplasms, RNA, Neoplasm, Werner Syndrome, Genes, Tumor Suppressor, CpG Islands, DNA Methylation, Gene Silencing, MicroRNAs, Epigenesis, Genetic, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.